US Dollar vs MXN

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

LIV

Emles at Home ETF (LIV)

Emles at Home ETF

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:LIV

Fecha	Hora	Fuente	Título	Símbolo	Compañía
16/09/2022	16:00	PR Newswire (US)	Emles Advisors Announces Closure of Six Funds	AMEX:LIV	Emles at Home ETF
13/12/2007	09:15	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc - Current report filing (8-K)	AMEX:LIV	Emles at Home ETF
19/11/2007	11:52	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc - Quarterly Report (10-Q)	AMEX:LIV	Emles at Home ETF
15/11/2007	13:16	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc - Notification that Quarterly Report will be submitted late (NT 10-Q)	AMEX:LIV	Emles at Home ETF
13/11/2007	05:06	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc (Other)	AMEX:LIV	Emles at Home ETF
08/11/2007	09:06	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc - Current report filing	AMEX:LIV	Emles at Home ETF
01/10/2007	09:00	Edgar (US Regulatory)	Samaritan Pharmaceuticals Inc (Other) (8-K)	AMEX:LIV	Emles at Home ETF
15/06/2006	09:09	Business Wire	Samaritan to Initiate Phase III Clinical Trial in Europe to Accelerate Development Timeline of Its HIV Oral Entry Inhibitor SP0	AMEX:LIV	Emles at Home ETF
30/05/2006	07:59	Business Wire	Samaritan Reports Positive Preliminary Results with ''Oral'' HIV Entry Inhibitor in Phase II 10-Day HIV Monotherapy Trial	AMEX:LIV	Emles at Home ETF
23/05/2006	08:22	Business Wire	Samaritan Files Provisional Patent to Support Promising New Type of Anti-cholesterol Drug SP-1000 and Cover Additional Claims;	AMEX:LIV	Emles at Home ETF
02/05/2006	08:15	Business Wire	Samaritan Starts Enrolling for Its PII Stage 2 (28 Day Monotherapy) Study of ''Oral'' Entry Inhibitor SP-01A	AMEX:LIV	Emles at Home ETF
25/04/2006	07:00	Business Wire	SIS Foundation Driven to Drive Bio Future Bus So Kids Can Speed up Science Innovation; Only 17% of US Students Graduate with Sc	AMEX:LIV	Emles at Home ETF
13/04/2006	12:13	Business Wire	Bio 2006 Analysts Predict Small-Cap Biotechs to Outperform Large-Caps This Year	AMEX:LIV	Emles at Home ETF
06/04/2006	07:30	Business Wire	LIV to Host Annual Shareholders Meeting	AMEX:LIV	Emles at Home ETF
04/04/2006	08:15	Business Wire	Samaritan's Marketing Authorization Application For Amphocil Approved in Greece	AMEX:LIV	Emles at Home ETF
30/03/2006	08:15	Business Wire	Samaritan to Present Its Drugs and Diagnostics for Partnering at BIO 2006 Annual International Conference	AMEX:LIV	Emles at Home ETF
28/03/2006	08:27	Business Wire	New Preclinical Data Shows Samaritan's Cardiovascular Drug Reduces Cholesterol; Cardiovascular Disease is a $15B Market Worldwi	AMEX:LIV	Emles at Home ETF
23/03/2006	08:30	Business Wire	Samaritan is the Little Biotech That Could Be Remembered for Alzheimer's	AMEX:LIV	Emles at Home ETF
21/03/2006	22:01	Business Wire	CORRECTING and REPLACING Samaritan's Adult Stem Cell Drug Displays Money-Making Signs	AMEX:LIV	Emles at Home ETF
21/03/2006	09:29	Business Wire	Samaritan's Adult Stem Cell Drug Displays Money-Making Signs	AMEX:LIV	Emles at Home ETF
09/03/2006	07:00	Business Wire	UPDATE: Samaritan Kicks Off Follow-On HIV Study	AMEX:LIV	Emles at Home ETF
01/03/2006	07:00	Business Wire	Distinguished Cancer Drug Developer Joins Samaritan Scientific Advisory Board	AMEX:LIV	Emles at Home ETF
28/02/2006	07:00	Business Wire	Samaritan's Alzheimer's Drug Registered as CAPROSPINOL; SP-233 (Caprospinol) is Believed to Exhibit Neuroprotective Properties	AMEX:LIV	Emles at Home ETF
24/02/2006	06:00	Business Wire	SIS Foundation Poses CSI Bio-Future Bus as Solution to Time Magazine's, Is America Flunking Science?	AMEX:LIV	Emles at Home ETF
14/02/2006	04:00	Business Wire	Samaritan Devoted to Pipeline Success	AMEX:LIV	Emles at Home ETF
09/02/2006	08:58	Business Wire	Samaritan Announces $40 Million Common Stock Purchase Agreement and Compliance with AMEX Additional Share Registration	AMEX:LIV	Emles at Home ETF
02/02/2006	07:00	Business Wire	New Innovative Drugs to Treat Mitochondrial Diseases Exclusively Licensed to Samaritan	AMEX:LIV	Emles at Home ETF
01/02/2006	07:00	Business Wire	Samaritan Pharmaceuticals' Subsidiary Certified as a CDE for New Market Tax Credit Program	AMEX:LIV	Emles at Home ETF
18/01/2006	07:00	Business Wire	Golden Globe/Academy Award Winner John Williams and Boston Pops Concert Benefiting the Samaritan Foundation Tentatively Schedule	AMEX:LIV	Emles at Home ETF
13/01/2006	07:00	Business Wire	New FDA Rules Expected to Expedite Testing of Samaritan's Drugs	AMEX:LIV	Emles at Home ETF

Showing the most relevant articles for your search:AMEX:LIV

Energy Select Sector SPDR

Health Care Select Sector

Euro vs US Dollar

Financial Select Sector

JP Morgan Chase

Verizon Communications

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones